ÂÜÀòÂÒÂ×

Marina Besprozvannaya is a seasoned professional in the field of biochemistry and product development, currently serving as Senior Manager of IVD Product Development at Grifols since July 2021. Marina's expertise includes leading teams in the development of IVD immunoassays for clinical diagnostics and managing projects focused on recombinant proteins and antibodies. Prior experience includes roles as Group Lead and Scientist at Cerus, where Marina contributed to pathogen inactivation technologies and led projects for next-generation INTERCEPT products. Additionally, Marina worked at Actym Therapeutics as a Scientist in immuno-oncology, and held research positions at renowned institutions such as the University of California, Davis, and Harvard University, where notable research on gene regulation and chromosome segregation was conducted. Marina earned a PhD in Biochemistry and an MA in Biology from Harvard University, complemented by a BA in Molecular and Cell Biology and Political Science from the University of California, Berkeley.